The Ozempic Shortage Is Over
The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive ...
Novo Nordisk’s OZEMPIC Approval Heat Up the Chronic Kidney Disease Therapeutic Market | DelveInsight
The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through third-party telehealth providers.
Crain's Chicago Business2d
Illinois AG urges FDA crackdown on 'counterfeit' GLP-1s
Kwame Raoul is among several state AGs raising the alarm following complaints about online teleheath company Hims & Hers ...
Hosted on MSN3d
Osteoporosis Biosimilar OK'd; New Endo Guidelines; A Hot Spot for Stealing Ozempic
The FDA approved the denosumab biosimilar Ospomyv, interchangeable with Prolia, for preventing osteoporosis-related fracture ...
Semaglutide Side Effects: Is It Safe? What You Need To Know
Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...
Medpage Today on MSN4d
Trump Cuts Target CDC Training; Bird Flu Admissions Rise; Ozempic Theft Spree
MedPage Today is collecting stories of HHS staffers across all agencies affected by Trump administration cuts. If you want to ...